The market expectations were tall. it was at TTM 37 p/e before results. The results are sort of a mixed bag.
1. The revenue growth was ONLY 4% QoQ. That's low given that even larger ones like Infy are growing at 7% QoQ.
1. The revenue growth was ONLY 4% QoQ. That's low given that even larger ones like Infy are growing at 7% QoQ.
In b/w lines: Management mentions that main reason is seasonality. Furlows in Q3 (lot of client development also stops in Q3). Management also mentions that 9M growth is 29% so longer term growth is strong.
Keep in mind that mastek attrition has always been high (20%+ even 2 years ago).
3. Someone on Valuepickr did a wonderful analysis. Generally, mastek's revenue in Quarter X+1 is 48% of order book in quarter X. The slowdown in current quarter was baked in in Q2 itself. See for yourself.
forum.valuepickr.com
Based on this we might see 10% growth in Q3.
forum.valuepickr.com
Based on this we might see 10% growth in Q3.
4. Diversification across platforms.
Co is mainly focussed on oracle due to evosys aquisition. At same time they are present in AWS & microsoft value chains (Dev ops, Azure). Focus is on winning in Oracle ERP space. This space is huge. so large opportunity size imo.
Co is mainly focussed on oracle due to evosys aquisition. At same time they are present in AWS & microsoft value chains (Dev ops, Azure). Focus is on winning in Oracle ERP space. This space is huge. so large opportunity size imo.
Not interested in sharing granular buy or sell decisions.
Do your own due diligence. Do not follow anyone blindly. Listen to concall, read investor presentation. Make up your own mind.
bseindia.com
Do your own due diligence. Do not follow anyone blindly. Listen to concall, read investor presentation. Make up your own mind.
bseindia.com
Loading suggestions...